Attorney General Frosh Joins Coalition in Motion to Unseal Generic Drug Price Fixing Complaint

News Release, Office of Maryland Attorney General Brian Frosh

BALTIMORE, MD (June 7, 2019) – Maryland Attorney General Brian E. Frosh joined a 44-state coalition in a motion today to unseal their complaint against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers. The complaint, filed on May 10 in U.S. District Court for the District of Connecticut, alleges a broad conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for more than 100 different drugs.

“The public should be allowed to see the lengths to which these drug companies went in their conspiracy to artificially inflate and manipulate drug prices, among other illegal activities. Their actions harmed people who use these drugs to treat a wide variety of life-threatening illnesses, including diabetes, asthma, epilepsy, and hypertension,” said Attorney General Frosh.

This complaint is the second to be filed in an ongoing, expanding investigation. The first complaint was similarly filed under seal initially, and later released in full with permission from the court.